Background and objective: Peak aerobic capacity (VO 2 peak) is an important outcome measure in cystic fibrosis (CF), but measurement is not widely available and can be influenced by patient motivation, pain and fatigue. Alternative markers of disease severity would be helpful. Neural respiratory drive, measured using parasternal intercostal muscle electromyography (EMGpara), reflects the load to capacity balance of the respiratory system and provides a composite measure of pulmonary function impairment in CF. The aim of the study was to investigate the relationship between exercise capacity, EMGpara and established measures of pulmonary function in clinically stable adult CF patients. Methods: Twenty CF patients (12 males, median (range) age: 22.3 (17.0-43.1) years) performed the 10-m incremental shuttle walk test (ISWT) maximally with contemporaneous measures of aerobic metabolism. EMGpara was recorded from second intercostal space at rest and normalized using peak electromyogram activity obtained during maximum respiratory manoeuvres and expressed as EMGpara%max (EMGpara expressed as a percentage of maximum). Results: VO 2 peak was strongly correlated with ISWT distance (r = 0.864, P < 0.0001). Lung gas transfer (T L CO) % predicted was best correlated with VO 2 peak (r = 0.842, P < 0.0001) and ISWT distance (r = 0.788, P < 0.0001). EMGpara%max also correlated with VO 2 peak (−0.757, P < 0.0001), while the relationships between exercise outcome measures and forced expiratory volume in 1 s (FEV 1 ) % predicted and forced vital capacity (FVC) % predicted were less strong. A T L CO% predicted of <70.5% was the strongest predictor of VO 2 peak <32 mL/min/kg (area under the curve (AUC): 0.96, 100% sensitivity, 83.3% specificity). ISWT distance and EMGpara%max also performed well, with other
INTRODUCTION
Forced expiratory volume in 1 s (FEV 1 ) and the rate of its decline are the most commonly used clinical predictors of survival in cystic fibrosis (CF). [1] [2] [3] 
SUMMARY AT A GLANCE
A novel marker of cystic fibrosis (CF) lung disease severity, inspiratory muscle electromyogram activity, was investigated in 20 adult CF patients. Both lung gas transfer (T L CO) % predicted and inspiratory muscle electromyogram activity related strongly to exercise performance and therefore may be useful in CF lung disease management.
insensitive to small treatment responses 4 and poorly related to symptoms. 5 Recent advances in CF care have highlighted the prognostic insensitivity of FEV 1. 6 Lung clearance index (LCI) is more sensitive to changes in CF lung disease severity than FEV 1, 7 but measurement remains limited primarily to the research setting.
The significant load imposed on the cardiovascular and respiratory systems during exercise testing can reveal pathophysiological changes associated with disease progression that are not detected using spirometry. Peak aerobic capacity (VO 2peak ) is related to quality of life, 8 and is a strong predictor of hospitalization 9 and mortality 10, 11 in adult CF patients. Exercise testing, however, not only requires specialist equipment and personnel, but also significant patient motivation. Some individuals are unable to exercise maximally due to pain and fatigue.
Indices which reflect both the airway obstruction and lung hyperinflation that occur in CF lung disease may provide more accurate markers of disease severity. Measurement of neural respiratory drive (NRD), obtained during resting tidal breathing using parasternal intercostal muscle electromyography (EMGpara), has been shown to provide a sensitive, easily applied indicator of load on the respiratory system that reflects lung disease severity in CF. 12, 13 We wished, therefore, to test the hypothesis that indices which reflect the overall impact of the pathophysiological changes that occur in CF lung disease would most strongly relate to exercise performance as assessed by the 10-m incremental shuttle walk test (ISWT) in clinically stable adult CF patients and could, therefore, provide more robust markers of disease severity in CF.
METHODS
Clinically stable adult CF patients were recruited from King's College Hospital, London, between January and July 2014. The study received local research ethics committee approval (South London (Dulwich) LREC Ref No 05/Q0703/82) and written informed consent was obtained.
Measurements
Spirometry, lung gas transfer (T L CO) and its components (transfer coefficient (KCO) and alveolar volume (Va)) and lung volumes using body plethysmography were measured (Jaeger Masterscreen, CareFusion, Würzburg, Germany). Height and weight were measured, and BMI was calculated. Fat-free mass (FFM) was determined by bioelectrical impedance (Bodystat 1500, Bodystat Ltd., Isle of Man, Bodystat, UK).
Surface EMGpara was recorded from the second intercostal space as previously described. 12 Resting EMGpara was measured during 5 min of relaxed breathing and the average value per breath calculated from the final minute. EMGpara was expressed as a percentage of the maximum value (EMGpara%max) achieved during a maximal volitional inspiratory manoeuvre. Three manoeuvres were performed at least five times: inhalation to total lung capacity (TLC) from functional residual capacity (FRC), maximal inspiratory pressure (PImax) and sniff nasal inspiratory pressure (SNIP). Maximal pressures were recorded for PImax and SNIP. The greatest peak EMGpara regardless of the manoeuvre performed was selected to normalize EMGpara. 12, 14 For more details, see Appendix S1 (Supplementary Information).
Exercise capacity was assessed using the ISWT as previously described 15 with the distance achieved recorded. During the ISWT, ventilatory and metabolic variables were measured using a portable exercise system (Metamax 3b, Cortex Medical, Leipzig, Germany) and oxygen saturation was recorded using pulse oximetry.
Protocol
All measurements were made during a single visit. EMGpara was measured initially followed by the maximal inspiratory manoeuvres, then pulmonary function followed by the ISWT.
Data analysis
All data expressed as median (range). Relationships between variables were assessed using Spearman correlation analysis. Change from rest to end exercise assessed using Wilcoxon matched-pairs signed-rank test. Mann-Whitney test was used to compare variables between patients with a VO 2 peak > 32 mL/min/kg to those with a VO 2 peak < 32 mL/min/kg. Receiver operator characteristic (ROC) analysis was used to evaluate the predictive power of variables with respect to VO 2 peak < 32 mL/min/kg, using thresholds demonstrating optimum balance between sensitivity and specificity. Statistical analysis performed using Prism version 6.0 (GraphPad Software Inc., La Jolla, CA, USA). A P-value <0.05 was considered statistically significant, except for correlation analysis for which a Pvalue <0.01 was used to allow for the number of comparisons performed.
Mean (SD) EMGpara%max was 13.4 (7) in 15 patients with CF. 12 Studying 20 patients would provide a representative sample with a 5% margin of error at the 10% level.
RESULTS
Twenty adult patients, median (range) age of 22.3 (17.0-43.1) years (12 males), with stable CF were studied ( Table 1) . The patients had a range of disease severity as classified using FEV 1 z-score. Five had mild (median (range) FEV 1 % predicted: 95.2% (89.7-101.3)), 3 moderate (median (range) FEV 1 % predicted: 66.2% (65.0-68.8)), 2 severe (median (range) FEV 1 % predicted: 55.0% (48.3-61.6)) and 10 very severe airflow obstruction (median (range) FEV 1 % predicted: 38.1% (16-50.3)). Gas trapping and hyperinflation were also present as indicated by residual volume (RV)/TLC >25% and thoracic gas volume (TGV)/TLC >50% ( Table 1) .
All patients performed a maximal shuttle walk test as indicated by either a respiratory exchange ratio (RER) > 1.1 (n = 14), a maximum heart rate (HR) > 80% predicted (n = 4) or a maximum minute ventilation (Vemax) > 80% predicted (predicted from FEV 1 × 40) (n = 2). Median (range) ISWT distance was 645 m (280-880). All physiological variables changed significantly from baseline to end exercise (Table 2) (P < 0.001).
Median (range) VO 2 peak (23.9 mL/min/kg (16.8-38.7)) and aerobic capacity (VO 2 ) at AT (15.2 mL/min/kg (10.3-29.5)) indicated markedly reduced exercise capacity in this patient group overall. A strong correlation was observed between ISWT distance and VO 2 peak (r = 0.864, P < 0.0001). The relationship between VO 2 peak and ISWT distance was described by the regression equation and 95% CIs VO 2 peak = 1.789 (−4.91 to 8.49) + 0.0401 (0.03 to 0.05) × ISWT distance (Fig. 1) .
EMGpara%max reflected CF lung disease severity and was significantly correlated with T L CO% predicted, RV/TLC, FEV 1 % predicted and forced vital capacity (FVC) % predicted and Va% predicted (Table 3) .
T L CO% predicted showed the strongest relationship with exercise outcome measures, correlating significantly with VO 2 peak (r = 0.842, P < 0.0001), VO 2 at AT (r = 0.671, P = 0.0012) and ISWT distance (r = 0.788, P < 0.0001) ( Table 4) . T L CO% predicted showed the best correlation with end-exercise pulse oximetryderived oxygen saturation (SpO 2 ) (r = 0.64, P < 0.01). EMGpara%max was also significantly correlated with VO 2 peak, VO 2 at AT and ISWT distance ( Table 4) . The relationships between exercise capacity and other lung function and respiratory muscle parameters including FEV 1 % predicted and FVC% predicted were less strong (Table 4) . FFM correlated with ISWT distance.
Using the variables that correlated with VO 2 peak, patients with a VO 2 peak < 32 mL/min/kg had significantly higher EMGpara%max at rest and lower T L CO% predicted, ISWT distance and FVC% predicted than those with VO 2 peak > 32 mL/min/kg (Fig. 2) . Thresholds for predicting VO 2 peak < 32 mL/min/kg, together with sensitivity and specificity values and area under the ROC curve (AUC) for each measured variable are shown in Table 5 . A T L CO% predicted of <70.5% was the strongest predictor of VO 2 peak < 32 mL/min/kg (AUC: 0.96, 100% sensitivity, 83.3% specificity). ISWT and EMGpara%max also performed well, with other variables demonstrating poorer predictive ability (Table 5) .
DISCUSSION
The study examined the relationship between exercise capacity, EMGpara activity and pulmonary function in adult CF patients. EMGpara%max and T L CO% predicted were more strongly related to measures of exercise performance than FEV 1 . T L CO% predicted was most strongly related to VO 2 peak and ISWT distance and most accurately predicted VO 2 peak.
Exercise capacity was assessed using the ISWT with contemporaneous measurements of respiratory and metabolic variables. The ISWT has been shown to provide a valid assessment of maximal exercise capacity in individuals with chronic respiratory diseases. 16, 17 Patients performed the ISWT maximally and each test was conducted by an experienced practitioner. Although the ISWT was performed only once, all participants were accustomed to the test as part of their routine clinical assessment. Contemporaneous measurement of metabolic variables avoided comparison between results of exercise tests performed on two separate occasions. Exercise limitation in CF is multifactorial, hence not all patients will demonstrate respiratory limitation at end exercise; however, each patient was deemed to have reached limitation by at least one of the described criteria: RER > 1.1 representing metabolic limitation, HR > 80% predicted representing cardiac limitation or Vemax > 80% predicted representing ventilatory limitation.
To reduce contamination from adjacent postural muscles and ensure good quality EMGpara signals were acquired, patients adopted a relaxed seated position with arms supported and adaptive mains filtering and post-acquisition digital band-pass filtering were applied to minimize background electrical noise. Standardized electrode position and good electrical contact were adopted to minimize poor between-subject and between-occasion reproducibility. 18 EMG signal attenuation due to subcutaneous fat was not considered important as none of the patients were obese.
As expected, a strong correlation between ISWT distance and VO 2 peak was observed and the data broadly comparable to those obtained by Bradley et al. 19 (r = 0.95, P < 0.01) using a modified ISWT. 19 When compared in percentage terms to these data, 19 the steeper slope and lower intercept of the regression equation derived from the current data resulted in slightly lower values for VO 2 peak at the shorter ISWT distances (90% at 300 m) and higher values at the longer ISWT distances (118% at 900 m). These differences probably reflect the use of the modified ISWT by Bradley et al. and the inclusion of patients with greater exercise tolerance and higher VO 2 peak. Measures of exercise capacity were also strongly correlated with a number of pulmonary function variables and EMGpara%max. Overall, VO 2 peak, VO 2 at AT and ISWT distance were most strongly correlated with T L CO% predicted. The strength of the relationship between T L CO% predicted and VO 2 peak (r = 0.842) was similar to that observed between ISWT distance and VO 2 peak (r = 0.864), suggesting T L CO could be a useful marker of lung disease severity in CF patients particularly in those who are unable or unwilling to exercise maximally. Similarly, albeit less strong relationships were observed between EMGpara%max, VO 2 peak, VO 2 at AT and ISWT distance. Interestingly FEV 1 and RV/TLC were only moderately well correlated with markers of exercise capacity, reflecting previous findings on the strength of the relationships observed between pulmonary function and exercise performance. 6, 19 Pianosi et al. demonstrated that a VO 2 peak < 32 mL/ min/kg was associated with a 60% 8-year mortality in CF. 10 Our data indicated that patients with a VO 2 peak < 32 mL/min/kg had significantly lower levels of T L CO% predicted and higher levels of EMGpara%max as well as decreased ISWT distance, FEV 1 % predicted and FVC % predicted. Receiver operator curve analysis indicated that T L CO% predicted < 70.2% was the strongest predictor of a VO 2 peak < 32 mL/min/kg. Both ISWT distance and EMGpara%max also had good positive predictive accuracy, while FVC% predicted and FEV 1 % predicted performed less well. The relatively poorer predictive capacity of spirometric variables was most likely due to such measures only representing one aspect of the pathophysiological changes that occur in CF lung disease and hence do not fully reflect the range of factors which limit exercise in this patient group.
There are few data available concerning the relationship between exercise performance and T L CO in CF. Pastre et al. 20 demonstrated that T L CO and FEV 1 correlated with VO 2 peak, but that FEV 1 demonstrated the strongest relationship. The study did, however, involve bootstrapping to account for missing data for some variables including T L CO. Our results are similar in that FEV 1 did correlate with VO 2 peak, but that T L CO % predicted had the strongest relationship. Exercise tolerance in CF is multifactorial, only 30% of the variability in exercise performance has been attributed to airway obstruction. [20] [21] [22] [23] Gas exchange abnormalities have also been shown to affect exercise performance. [24] [25] [26] Small airway dysfunction leading to ventilation heterogeneity and ventilation perfusion mismatch alongside elevated venous admixture, intrapulmonary shunting and alveolar hypoventilation 7, 27, 28 have been implicated. T L CO reflects the lung volume available for gas exchange, gas diffusion and exchange across the alveolar membrane. In worsening CF lung disease, accessible Va decreases due to ventilation expressed as a percentage of maximum), lung gas transfer (T L CO), incremental shuttle walk test (ISWT) and forced vital capacity (FVC) % predicted and forced expiratory volume in 1 s (FEV 1 ) % predicted in patients achieving a peak aerobic capacity (VO 2 peak) < 32 mL/min/kg with those of >32 mL/min/kg. Horizontal lines indicate median heterogeneity and gas diffusion is impaired by suboptimal ventilation/perfusion relationships. By contrast, gas exchange across the alveolar membrane is not substantially reduced, as demonstrated in the current cohort by the relatively well-preserved KCO. When considered alongside the measured reductions in Va and the relationship of Va% predicted to VO 2 peak and VO 2 at AT and the relationship between T L CO% predicted and end-exercise SpO 2 , the current data suggest that it is the decreased accessible lung volume and impaired gas diffusion as measured using T L CO that contributed mostly to exercise impairment in this cohort of CF patients rather than airway obstruction.
The parasternal intercostal muscles are obligate inspiratory muscles recruited in tandem with the diaphragm, acting to prevent rib cage distortion and ventilatory inefficiency. EMGpara increases progressively alongside diaphragm EMG during exercise.
12 EMGpara provides a measure of NRD which, unlike measures such as spirometry that only measures a single aspect of respiratory function, reflects the combined effects of mechanical and metabolic load on the respiratory system. In CF, airway obstruction and lung hyperinflation increase the load on the respiratory muscles. Lung hyperinflation increases the elastic work of breathing and the development of intrinsic positive endexpiratory pressure which imposes a threshold load on each breath. Hyperinflation also reduces inspiratory muscle length leading to functional inspiratory muscle weakness. 29 NRD as measured by EMGpara increases to maintain ventilation at the appropriate level for blood gas homeostasis. The current data confirm our previous findings that EMGpara%max provides a sensitive indicator of load on the respiratory system which is related to disease severity in CF 12, 13 and demonstrate that this index provides an effort independent measure of exercise capacity which could be helpful in disease management.
EMGpara%max and T L CO% predicted were also strongly correlated with each other. As median KCO% predicted for the group was 99% and not significantly related to EMGpara%max, the current data suggest that the significant relationship between T L CO% predicted and EMGpara%max was primarily due to decrements in Va available for gas exchange. A significant correlation between EMGpara%max and Va% predicted was observed.
Although exercise limitation in CF has a large ventilatory component, it is also influenced by peripheral muscle function [30] [31] [32] and nutritional status 21 as indicated by the significant correlation between FFM and ISWT distance. Suboptimal peripheral muscle function results in decreased aerobic metabolism and early lactic acidaemia, 23, 31 resulting in reduced exercise capacity. Although T L CO and EMGpara%max were strongly correlated with physiological measures of exercise capacity, such measurements were performed at rest and therefore do not reflect both the influence of peripheral muscle dysfunction and the changes in lung function such as dynamic hyperinflation 12 that occur during exercise which influence exercise performance.
T L CO is not routinely measured in CF and is not part of CF care standards. 33 There is conflicting evidence as to the benefit of measuring T L CO in patients with CF. T L CO has been shown to be maintained until lung disease becomes more advanced 34 and hence is unhelpful prognostically. 35 Conversely, serial measurements have been shown to correlate with clinical severity in patients with advanced lung disease, unlike routine lung function tests such as FEV 1. 36,37 Although lung function indices such as FEV 1 and FVC are commonly used to assess CF lung disease severity, assessment of exercise performance is a key clinical and trial outcome tool in CF 33, 38 and measurement of VO 2 peak has been shown to better predict both mortality 10, 11, 39 and the risk of hospitalization. 9 Exercise testing with the aim of measuring VO 2 peak is, however, expensive and demanding on patients and therefore not always utilized in CF centres. This study has shown that measurements of T L CO% predicted, as well EMGpara%max were strongly related to exercise performance.
In conclusion, measurement of VO 2 peak is an important assessment tool in CF management. It is, however, not widely available and such testing can be negatively influenced by poor patient motivation, pain, fatigue as well as shortness of breath. Integrated measures of pulmonary function such as T L CO% predicted and EMGpara%max were related strongly to exercise performance in adult patients with CF and therefore may be of benefit in the assessment of CF lung disease severity. Table 5 Results of ROC analysis to predict VO 2 peak < 32 mL/min/kg. Area under the curve, sensitivity and specificity for T L CO% predicted, ISWT distance, EMGpara%max, FVC% predicted and FEV 1 
